Beginning 1 May 2025, in a significant move toward digital transformation, Thailand’s Food and Drug Administration (FDA) has officially...

To further enhance the ease of doing business and improve regulatory efficiency, the Central Licensing Authority has introduced a...

With the exponential rise of e-commerce in healthcare, China is taking significant steps to safeguard patient and product integrity...

In a move to enhance the regulation and traceability of medical device imports, the Medical Device Authority (MDA) has officially...

Starting 1 May 2025 , medicine labels in Australia will begin to phase out dual ingredient names and move towards using only the updated...

The Health Sciences Authority (HSA) is set to roll out a significant update to its regulatory infrastructure with the Singapore Health...

New legislation signed into law by the Medicines and Healthcare products Regulatory Agency (MHRA) on 11 April 2025  marks the start of a...

On the 17th of April 2025, the Drug Regulatory Authority of Pakistan (DRAP) released an update announcing a significant development in...

The Medical Device Authority (MDA) has announced a key regulatory update that impacts all stakeholders within the medical device and...

Starting 1 May 2025 , the Medical Device Authority (MDA) is pleased to announce that all product classification applications must be...

The International Medical Device Regulators Forum (IMDRF) has opened a critical consultation period for its Playbook for Medical Device...

The Department of Health and Family Welfare has taken a crucial step to support small and medium pharmaceutical manufacturers by granting...